H&A Pharmachem Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
May 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 19, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 21, 2026
- Nov 17 US 12,797,307 Cosmetic Composition for Molding, Comprising Calcined Layered Double Hydroxide and Polymer
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,372,395 | Nano-emulsion composition of coenzyme Q10 In force · USPTO record | In force | USPTO record | |
| US 8,686,039 | Aqueous nanoemulsion composition containing conjugated linoleic acid In force · USPTO record | In force | USPTO record | |
| US 9,457,083 | Liposome composition for treating acne containing conjugate of lysophosphatidylcholine and chlorin e6 In force · USPTO record | In force | USPTO record | |
| US 10,925,816 | Composition for transdermal delivery, comprising nanoemulsion and modified layered double hydroxide In force · USPTO record | In force | USPTO record | |
| US 11,260,010 | Cochelates using phosphatidylserine/anionic surfactant/calcium chloride In force · USPTO record | In force | USPTO record | |
| US 11,331,261 | Transdermal delivery complex using metal-organic framework and nanocellulose In force · USPTO record | In force | USPTO record | |
| US 12,797,307 | Cosmetic Composition for Molding, Comprising Calcined Layered Double Hydroxide and Polymer In force · High confidence | In force | High confidence | |
| US 12,465,562 | Transdermal delivery complex using metal-organic framework and triblock copolymer In force · USPTO record | In force | USPTO record | |
| US 12,453,692 | Transdermal delivery composite using covalent organic framework and polymer In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending